| Trial ID: | L1000 |
| Source ID: | NCT04145492
|
| Associated Drug: |
Vitamin K2
|
| Title: |
Effect of Vitamin K 2 on Vascular Calcification in Hemodialysis Patients
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Disease
|
| Interventions: |
DRUG: Vitamin K2|DRUG: Cholecalciferol (inactive vitamin D)|DRUG: Vitamin K2 and Cholecalciferol
|
| Outcome Measures: |
Primary: Uncarboxylated MGP, Measuring serum level of Uncarboxylated MGP as a marker for calcification, 4 months|Uncarboxylated osteocalcin, Measuring serum level of Uncarboxylated osteocalcin as a marker for calcification, 4 months |
|
| Sponsor/Collaborators: |
Sponsor: Ain Shams University
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2019-09-01
|
| Completion Date: |
2020-02-01
|
| Results First Posted: |
|
| Last Update Posted: |
2019-10-30
|
| Locations: |
Radwa Maher El Borolossy, Cairo, 0000, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT04145492
|
